Stay updated on HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.3 to the Study Record History. Footer-related items HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T20:32:00.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.2.0 to v3.3.2 on the page history. This change affects only the system version label and not the study information or user-facing content.
    Difference
    0.1%
    Check dated 2025-11-25T10:09:15.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The government funding lapse notice on the page was removed. This change does not affect core study information such as recruitment status, eligibility criteria, or study data; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2025-11-18T03:27:04.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    New version added to the Record History (2025-09-18) reflecting updated Study Status and related details.
    Difference
    0.1%
    Check dated 2025-11-03T17:09:13.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    - Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.
    Difference
    11%
    Check dated 2025-10-06T04:28:07.000Z thumbnail image
  9. Check
    105 days ago
    Change Detected
    Summary
    Page update to a newer revision (v3.1.0) with removal of the old revision (v3.0.2) and added topics (Study Status Oversight Contacts/Locations IPDSharing) and a date stamp.
    Difference
    2%
    Check dated 2025-09-29T01:13:58.000Z thumbnail image

Stay in the know with updates to HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HBI-8000 + Nivolumab vs. Nivolumab in Melanoma Clinical Trial page.